Product NDC: | 16590-267 |
Proprietary Name: | CLONIDINE HYDROCHLORIDE |
Non Proprietary Name: | CLONIDINE HYDROCHLORIDE |
Active Ingredient(s): | .2 mg/1 & nbsp; CLONIDINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-267 |
Labeler Name: | STAT Rx USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070317 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090903 |
Package NDC: | 16590-267-15 |
Package Description: | 15 TABLET in 1 BOTTLE (16590-267-15) |
NDC Code | 16590-267-15 |
Proprietary Name | CLONIDINE HYDROCHLORIDE |
Package Description | 15 TABLET in 1 BOTTLE (16590-267-15) |
Product NDC | 16590-267 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLONIDINE HYDROCHLORIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090903 |
Marketing Category Name | ANDA |
Labeler Name | STAT Rx USA LLC |
Substance Name | CLONIDINE HYDROCHLORIDE |
Strength Number | .2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |